Spero Therapeutics annual capital expenditures (capex)
2015
2016
2017
2018
2019
2020
Spero Therapeutics Capital Expenditures (CapEx) Growth & History (SPRO)
Spero Therapeutics's capital expenditures (capex) was $157,000 for fiscal 2020.
View full Spero Therapeutics company overviewSpero Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2020 | 2020-12-31 | $157,000 | −$157,000 | −50.00% |
| 2019 | 2019-12-31 | $314,000 | −$2.1M | −87.11% |
| 2018 | 2018-12-31 | $2.4M | $2.4M | +8922.22% |
| 2017 | 2017-12-31 | $27,000 | −$803,000 | −96.75% |
| 2016 | 2016-12-31 | $830,000 | $598,000 | +257.76% |
| 2015 | 2015-12-31 | $232,000 | — | — |
Spero Therapeutics quarterly capital expenditures (capex)
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q3.21
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q3 2021 | 2021-09-30 | $0 | −$51,000 | — |
| Q4 2020 | 2020-12-31 | $12,000 | −$117,000 | −90.70% |
| Q3 2020 | 2020-09-30 | $51,000 | $34,000 | +200.00% |
| Q2 2020 | 2020-06-30 | $15,000 | −$72,000 | −82.76% |
| Q1 2020 | 2020-03-31 | $79,000 | −$2,000 | −2.47% |
| Q4 2019 | 2019-12-31 | $129,000 | — | — |
| Q3 2019 | 2019-09-30 | $17,000 | — | — |
| Q2 2019 | 2019-06-30 | $87,000 | — | — |
| Q1 2019 | 2019-03-31 | $81,000 | — | — |
Spero Therapeutics capital expenditures (capex) trends
Over the last five fiscal years, Spero Therapeutics's capital expenditures (capex) decreased from $232,000 to $157,000, a change of −$75,000. The latest reported quarter, Q3 2021, shows $0.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Spero Therapeutics source filings ↗